The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Valle Franco since 2020.
This trader's CIK number is 1699848.
At the time of last reporting, Valle Franco was the Chief Financial Officer of Biomea Fusion, Inc.. (stock ticker symbol BMEA).
Also see all insider trading activities at Biomea Fusion, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | BMEA | 12,509 | $55,364 | 0 | $0 | 0 | $0 |
| 2022 | BMEA | 10,000 | $86,770 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | EIDX | 0 | $0 | 3,247 | $407,559 | 3,247 | $23,508 |
| 2020 | EIDX | 0 | $0 | 22,266 | $1,418,415 | 21,822 | $157,990 |
2. Eidos Therapeutics, Inc. (EIDX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-06-11 | BMEA | Buy | 12,509 | 4.43 | 55,364 |
| 2022-01-14 | BMEA | Buy | 10,000 | 8.68 | 86,770 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-01-11 | EIDX | Option Ex | 1,500 | 7.24 | 10,860 |
| 2021-01-12 | EIDX | Option Ex | 1,747 | 7.24 | 12,648 |
| 2021-01-11 | EIDX | Sale | 1,500 | 125.61 | 188,407 |
| 2021-01-12 | EIDX | Sale | 1,747 | 125.44 | 219,152 |
| 2020-11-09 | EIDX | Sale | 1,623 | 74.93 | 121,609 |
| 2020-11-09 | EIDX | Option Ex | 1,623 | 7.24 | 11,750 |
| 2020-10-07 | EIDX | Option Ex | 5,000 | 7.24 | 36,200 |
| 2020-10-08 | EIDX | Option Ex | 5,199 | 7.24 | 37,640 |
| 2020-10-07 | EIDX | Sale | 5,444 | 75.08 | 408,746 |
| 2020-10-08 | EIDX | Sale | 5,199 | 74.85 | 389,150 |
| 2020-04-20 | EIDX | Option Ex | 2,000 | 7.24 | 14,480 |
| 2020-04-20 | EIDX | Sale | 2,000 | 49.79 | 99,580 |
| 2020-03-26 | EIDX | Option Ex | 5,000 | 7.24 | 36,200 |
| 2020-03-26 | EIDX | Sale | 5,000 | 48.36 | 241,800 |
| 2020-03-02 | EIDX | Option Ex | 3,000 | 7.24 | 21,720 |
| 2020-03-02 | EIDX | Sale | 3,000 | 52.51 | 157,530 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Valle Franco (Chief Financial Officer of Biomea Fusion, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.